With the administrative stay from the FDA now in place, we continue to offer our products to adult smokers while we pursue the Agency’s internal review process. We remain confident in the quality and substance of our applications and believe that ultimately we will be able to demonstrate that our products do in fact meet the statutory standard of being appropriate for the protection of the public health. We now look forward to re-engaging with the FDA on a science- and evidence-based process to pursue a marketing authorization for JUUL products.
— Joe Murillo, Chief Regulatory Officer at Juul Labs
January 29, 2025
The U.S. International Trade Commission (ITC) issued a decision today affirming an Administrative Law Judge’s ruling that Altria’s NJOY ACE e-vapor products infringe four…
October 2, 2024
On September 26th, Juul Labs’ Chairman & Chief Executive Officer, K.C. Crosthwaite, delivered the keynote address at the 2024 Global Tobacco & Nicotine Forum,…
July 29, 2024
Juul Labs announced today the settlement with a group of noteholders that confirms the conversion of the convertible notes to equity, and provides an…